Vulval disease in the postmenopausal patient: A guide to current management

Menopause International

Volumn 16, Issue 3, 2010, Pages 117-120

  Kingston, Abigail ^a  

^a SALISBURY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Lichen sclerosis; Postmenopausal; Vulval atrophy; Vulval disease

Indexed keywords

ANTIHISTAMINIC AGENT; CLOBETASOL PROPIONATE; ESTRADIOL; STEROID; TACROLIMUS;

ANAMNESIS; BEDTIME DOSAGE; CLINICAL FEATURE; CONTACT DERMATITIS; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; FEMALE; HUMAN; IRRITANT DERMATITIS; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; LOW DRUG DOSE; NEURODERMATITIS; POSTMENOPAUSE; PRACTICE GUIDELINE; REVIEW; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA; SYMPTOM; VULVA DISEASE; VULVA PRURITUS; VULVOVAGINITIS;

ADMINISTRATION, TOPICAL; DERMATITIS, CONTACT; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; NEURODERMATITIS; POSTMENOPAUSE; PRACTICE GUIDELINES AS TOPIC; SEXUAL BEHAVIOR; VULVAR DISEASES; VULVOVAGINITIS;

EID: 78049455189     PISSN: 13621807     EISSN: 17404568     Source Type: Journal    
DOI: 10.1258/mi.2010.010031     Document Type: Review

References (15)

1. Cumming GP, Herald J, Moncur R, Currie H, Lee AJ. Women's attitudes to hormone replacement therapy, alternative treatments and sexual health. Menopause Int 2007;13:79-83
2. Pastore LM, Carter RA, Hulka BS, et al. Self-reported urogenital symptoms in postmenopausal women: women's health initiative. Maturitas 2004;49:292-303 (Pubitemid 39505183)
3. Summers P, Hunn J. Unique dermatologic aspects of the postmenopausal vulva. Clin Obstet Gynaecol 2007;50:745-51 (Pubitemid 47357247)
4. Simonart T, Lahaye M, Simonart JM. Vulvar lichen sclerosus: effect of maintenance treatment with a moisturizer on the course of the disease. Menopause: the Journal of the North American Menopause Society 2008;15:74-7
5. Lynch PJ, Edwards L. Genital Dermatology. New York: Churchill Livingstone, 1994
6. Farage MA, Miller KW, Ledger WJ. Determining the cause of vulvovaginal symptoms. Obstet Gynaecol Surv 2008;63(7):445-62
7. Neill SM, Tatnall FM, Cox NH. Guidelines for the management of lichen sclerosus. Br J Dermatol 2002;147:640-9
8. Renaud-Vilmer C, Cavelier-Balloy B, Porcher R, Dubertret L. Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. Arch Dermatol 2004;140:709-12 (Pubitemid 38747287)
9. Lynch P, Moyal-Barracco M, Bogliatto F, et al. 2006 ISSVD classi- fication of vulvar dermatoses: pathologic subsets and their clinical correlates. J Reprod Med 2007;52:3-9
10. Lorenz B, Kaufman R, Kutzner S. Lichen sclerosus. Therapy with clobetasol propionate. J Reprod Med 1998;43:790-4 (Pubitemid 28430693)
11. Cardozo L, Bachmann G, McClish D, et al. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998;92:722-27 (Pubitemid 28440818)
12. Mehta A, Bachmann G. Vulvovaginal complaints. Clin Obstet Gynaecol 2008;51:549-55
13. Goldstein AT, Metz A. Vulvar lichen planus. Clin Obstet Gynaecol 2005;48:818-23
14. Preti M, Van M, Sideri M, Van M. Squamous vulvar Intraepithelial Neoplasia. Clin Obstet Gynaecol 2005;4:845-61
15. Maclean AB, Makwana M, Ellis P, Cunnington F. The management of Paget's disease of the vulva. J Obstet Gynaecol 2004;24:124-8